eli lilly trials retatrutide Medscape | Retatrutide, Lilly's first-in-class triple hormone receptor agonist, delivered meaningful weight loss at 80 weeks in all doses in the Retatrutide Exhibits Meaningful Weight Loss
Pay in 4 interest-free payments of $5.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3













00188-2/asset/060af149-96d8-44a2-9e4d-318ecc8ae69e/main.assets/gr1_lrg.jpg)









